Immune to Cancer: The CRI Blog
-
White Out Cancer 2015
More than 1,000 posts from around the globe were shared in the third annual event.
-
CRI Member to Chair Immuno-Oncology 360 Conference
Dr. Axel Hoos, a member of the CRI Scientific Advisory Council, will chair and be the keynote…
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO
Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer…
-
ASCO 2015: Report from Day 5
The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 3
Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.
-
ASCO 2015: Report from Day 2
The latest results from clinical trials of checkpoint inhibitors for lung cancer, liver cancer, and more.
-
ASCO 2015: Report from Day 1
A day for travel and educational sessions at the American Society of Clinical Oncology (ASCO).
-
ASCO 2015: 3 Tips for Patients
Tips for patients looking to follow the breaking cancer treatment news from ASCO 2015
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.